Without a doubt, the cell therapy industry is coming of age. In addition to growing numbers of cell therapy clinical trials, there are 17 cell therapy products that have been approved worldwide and 150+ cell therapy companies competing in the global marketplace. These metrics are extremely important, because they indicate that the market for cell therapy products is expanding.
However, one of the most telling trends within the industry is a growing interest among “big pharma” in cell therapy companies. At its core, this is a strategic way for pharmaceutical companies to diversity their product development pipeline. [Read more…]